Indivior Pharmaceuticals, Inc. (INDV): Cash & Equivalents
$195.00M
As of 2025-12-31
$222.00M
As of 2026-06-30
| Period ended | Cash & Equivalents | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $195.00M | -38.9% | 2026-02-26, Balance as of period end |
| 2024-12-31 | $319.00M | +0.9% | 2026-02-26, Balance as of period end |
| 2023-12-31 | $316.00M | n/a | 2025-03-03, Balance as of period end |
Cash & Equivalents at similar companies
| Company | Year ended | Cash & Equivalents | Change YoY |
|---|---|---|---|
| Indivior Pharmaceuticals, Inc. (INDV) | 2025-12-31 | $195.00M | -38.9% |
| Prestige Consumer Healthcare Inc. (PBH) | 2026-03-31 | $63.87M | -34.8% |
| Acadia Pharmaceuticals Inc (ACAD) | 2025-12-31 | $177.69M | -44.4% |
| Alkermes plc. (ALKS) | 2025-12-31 | $388.57M | +33.5% |
| Phibro Animal Health Corp (PAHC) | 2026-06-30 | $61.42M | -9.7% |
| Madrigal Pharmaceuticals, Inc. (MDGL) | 2025-12-31 | $198.69M | +98.7% |
| Ionis Pharmaceuticals Inc (IONS) | 2025-12-31 | $372.26M | +53.8% |
| PTC Therapeutics, Inc. (PTCT) | 2025-12-31 | $984.65M | +26.3% |
| ANI Pharmaceuticals Inc (ANIP) | 2025-12-31 | $285.58M | +97.1% |
Compare INDV, PBH, ACAD, ALKS side by side · Screen every company in Pharmaceutical Preparations ↗